Collagen synthesis in vaginal mucosa

Collagen synthesis in the vaginal mucosa refers to the cellular processes responsible for producing structural collagens—mainly types I and III—that form the extracellular matrix supporting the integrity, elasticity, and biomechanical properties of vaginal tissues. This synthesis is regulated by hormonal status—especially estrogen—and involves complex interactions between fibroblasts, growth factors like TGF-beta, enzymes such as lysyl oxidase, matricellular proteins including fibulin‑5/LOXL1, and other ECM regulators. Disruption leads to conditions such as vulvovaginal atrophy seen post-menopause due to decreased estrogen levels or pelvic organ prolapse due to weakened connective tissues. Therapeutic strategies aim either at restoring normal collagen content through hormone replacement therapy or novel approaches using bioactive compounds like quercetin or recombinant human collagens that promote local regeneration without systemic side effects.

Other names

Vaginal collagen biosynthesisCollagen production in vaginal tissueExtracellular matrix formation in vagina

Drugs that influence this process act by: - Stimulating fibroblast activity and proliferation - Enhancing expression of extracellular matrix proteins including collagens and elastin - Modulating growth factor pathways such as TGF-beta signaling to regulate ECM turnover and remodeling